Analysis of Prognostic Determinants of Scleroderma-Associated Pulmonary Arterial Hypertension and Idiopathic Pulmonary Arterial Hypertension

被引：0
|
作者：
Hannan, Alexander [1 ]
Dweik, Raed [2 ]
Highland, Kristin B. [3 ]
Heresi, Gustavo [4 ]
Tonelli, Adriano [4 ]
Messner, William [5 ]
Chatterjee, Soumya [1 ]
机构：
[1] Cleveland Clin, Rheumat & Immunol Dis, Cleveland, OH 44106 USA
[2] Cleveland Clin, Resp Inst, Cleveland, OH 44106 USA
[3] Cleveland Clin, Rheumatol Org, Cleveland, OH 44106 USA
[4] Cleveland Clin, Resp Inst, Pulm Med, Cleveland, OH 44106 USA
[5] Cleveland Clin, Quantitat Hlth Sci, Cleveland, OH 44106 USA
来源：
ARTHRITIS & RHEUMATOLOGY | 2017年 / 69卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
2680
引用
收藏
页数：4
相关论文
共 50 条
  • [41] Bosentan for the treatment of pulmonary arterial hypertension associated to scleroderma
    Hachulla, E.
    Launay, D.
    Humbert, M.
    REVUE DE MEDECINE INTERNE, 2007, 28 : S221 - S226
  • [42] Recent advances in scleroderma-associated pulmonary hypertension
    Highland, Kristin B.
    CURRENT OPINION IN RHEUMATOLOGY, 2014, 26 (06) : 637 - 645
  • [43] Significant improvement of right ventricular function by imatinib mesylate in scleroderma-associated pulmonary arterial hypertension
    Henrik ten Freyhaus
    Daniel Dumitrescu
    Henning Bovenschulte
    Erland Erdmann
    Stephan Rosenkranz
    Clinical Research in Cardiology, 2009, 98 : 265 - 267
  • [44] Follow-up haemodynamic assessment as a predictor of survival in scleroderma-associated pulmonary arterial hypertension
    Kotecha, T.
    Schreiber, B. E.
    Handler, C. E.
    Denton, C. P.
    Coghlan, J. G.
    EUROPEAN HEART JOURNAL, 2016, 37 : 156 - 156
  • [45] NKX2-5 regulates vessel remodeling in scleroderma-associated pulmonary arterial hypertension
    Papaioannou, Ioannis
    Dritsoula, Athina
    Kang, Ping
    Baliga, Reshma S.
    Trinder, Sarah L.
    Cook, Emma
    Shiwen, Xu
    Hobbs, Adrian J.
    Denton, Christopher P.
    Abraham, David J.
    Ponticos, Markella
    JCI INSIGHT, 2024, 9 (10)
  • [46] Significant improvement of right ventricular function by imatinib mesylate in scleroderma-associated pulmonary arterial hypertension
    ten Freyhaus, Henrik
    Dumitrescu, Daniel
    Bovenschulte, Henning
    Erdmann, Erland
    Rosenkranz, Stephan
    CLINICAL RESEARCH IN CARDIOLOGY, 2009, 98 (04) : 265 - 267
  • [47] PROGNOSTIC FACTORS FOR SURVIVAL IN IDIOPATHIC PULMONARY ARTERIAL HYPERTENSION
    Popplewell, C. R.
    Greenhalgh, A.
    Corris, P. A.
    THORAX, 2017, 72 : A176 - A176
  • [48] Idiopathic Pulmonary Arterial Hypertension and Pulmonary Arterial Hypertension Associated With Congenital Heart Disease in Chinese Children: Similarities, Differences, and Prognostic Factors
    Gu, Li
    Li, Yuan Yuan
    Gu, Ling
    Xie, Liang
    Liu, Han Min
    FRONTIERS IN PEDIATRICS, 2020, 8
  • [49] Ambrisentan and Tadalafil Up-front Combination Therapy in Scleroderma-associated Pulmonary Arterial Hypertension
    Hassoun, Paul M.
    Zamanian, Roham T.
    Damico, Rachel
    Lechtzin, Noah
    Khair, Rubina
    Kolb, Todd M.
    Tedford, Ryan J.
    Hulme, Olivia L.
    Housten, Traci
    Pisanello, Chiara
    Sato, Takahiro
    Pullins, Erica H.
    Corona-Villalobos, Celia P.
    Zimmerman, Stefan L.
    Gashouta, Mohamed A.
    Minai, Omar A.
    Torres, Fernando
    Girgis, Reda E.
    Chin, Kelly
    Mathai, Stephen C.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2015, 192 (09) : 1102 - 1110
  • [50] Longterm Survival Among Patients with Scleroderma-associated Pulmonary Arterial Hypertension Treated with Intravenous Epoprostenol
    Badesch, David B.
    McGoon, Michael D.
    Barst, Robin J.
    Tapson, Victor F.
    Rubin, Lewis J.
    Wigley, Fredrick M.
    Kral, Kenneth M.
    Raphiou, Ibrahim H.
    Crater, Glenn D.
    JOURNAL OF RHEUMATOLOGY, 2009, 36 (10) : 2244 - 2249
12345